ZIKA

At the First International Conference on Zika Virus, Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, discussed how an international registry can help estimate the risk of Zika virus associated with birth defects and abnormal pregnancy outcomes.

On Friday, February 24, 2017, at the First International Conference on Zika Virus, Matthew Aliota, PhD, discussed the Eliminate Dengue Program.

Viviane Boaventura, MD, PhD, researcher, Fiocruz-Bahia, Gonçalo Moniz Institute, Brazil, discusses her research regarding impaired hearing function due to congenital Zika syndrome.

Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, explains how data sharing may be used to answer important questions regarding congenital Zika syndrome.

Both Zika-infected and uninfected pregnant women showed levels of high stress in a recent study conducted in Puerto Rico.

Matthew Aliota, PhD, research scientist, University of Wisconsin, Pathobiological Sciences, explains why the mechanism behind how Wolbachia blocks Dengue virus transmission is not yet fully understood.

At the First International Conference on Zika Virus, Marta G. Cavalcanti, MD, PhD, discussed her team’s recent research regarding viral RNA shedding in symptomatic and asymptomatic Zika patients who are either mono-infected with Zika or Chikungunya, or co-infected with both.

At the First International Zika Conference, keynote speaker Annelies Wilder-Smith, MD, PhD, DTM&H, MIH, FAMS, FACTM, discussed how Zika has evolved on a global scale.

Marta G. Cavalcanti, MD, PhD, physician at Infectious Diseases Clinic, Hospital Universitario Clementino Fraga Filho, UFRJ, Brazil, discusses how the period of RNA shedding correlates with the severity of complications associated with mono- or coinfection in Zika patients.

In the first study to examine multiple body fluids for the presence of Zika virus in an ongoing fashion, researchers discover Zika virus remains in bodily fluids longer than other flaviviruses.

Contagion® will be attending the conference, so keep a look out for session coverage, as well as interviews with some of the key presenters.

Results from Zika virus testing conducted by the District of Columbia Department of Forensic Sciences Public Health Laboratory between July 14, 2016 and December 14, 2016 raised red flags when all results came back negative.

Researchers have found that the Zika virus uses receptor tyrosine kinase AXL to slip past major barrier cell types in the placenta.

Researchers from Emory Vaccine Center study human dendritic cells infected with contemporary and historical strains of the Zika virus.

Contagion® is celebrating it’s one-year anniversary today, February 7, 2017. As we hit this milestone, we wanted to look back and remember the three articles that launched Contagion® on this day in 2016.

The Texas Department of State Health Services recently reported the first laboratory-confirmed case of Zika virus in pregnant woman who did not travel outside of the state.

Researchers from La Jolla Institute for Allergy and Immunology believe that their findings will provide a platform to understand how Zika virus makes its way into various body fluids.

As concerns over the spread of tropical infectious diseases increase, in the age of Zika virus and Dengue fever in particular, PRVs may have significant implications for the development of novel vaccines and antivirals, assuming the program is used effectively.

The researchers evaluated populations of Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus collected both in the field and raised in a lab setting to determine whether or not the mosquitoes required bacterial populations in their guts to develop, and which bacteria were necessary to the process.

Researchers from Germany recently published a new study that can change how future scientists study the replication of the Dengue and Zika viruses within the human body.

Researchers have found that it is possible to bolster the immunity of the Aedes aegypti mosquito, the species that transmits Dengue, Zika, and Chikungunya, against these viruses and effectively suppress its ability to transmit the disease.

A team of dermatologists and gynecologists recently described their work with a 23-year-old pregnant woman in Florida who was eventually confirmed as the first documented case of Zika virus infection acquired via a mosquito bite sustained in the local area.

The year 2016 may be over, but the fight against the infectious disease that dominated headlines for most of the year—Zika virus—has only just begun.

While more information on the Zika virus is revealed, researchers are saying that the United States can rest a little easier over concerns of a large-scale outbreak.

A new coalition created by the Bill & Melinda Gates Foundation and other global partners will launch at this year’s World Economic Forum, with the goal of supporting the fast-tracked development of new vaccines.

Researchers from the National Institutes of Health recommend integrating men into the family-planning process in the age of Zika.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses efforts to understand the Zika virus.

Daniel Eiras, MD, MPH, hospital epidemiologist at NYU Langone Medical Center, discusses Zika response at NYU Langone Medical Center.

Contagion’s Top Five Zika-related news stories over the past year are included in this article.